The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
Open accessAbstract
Leptomeningeal metastasis (LM) results from metastatic spread of cancer to the leptomeninges, giving rise to central nervous system dysfunction. Breast cancer, lung cancer, and melanoma are the most frequent causes of LM among solid tumors in adults. An early diagnosis of LM, before fixed neurologic deficits are manifest, permits earlier and potentially more effective treatment, thus leading to a better quality of life in patients so affected. Apart from a clinical suspicion of LM, diagnosis is dependent upon demonstration of cancer in cerebrospinal fluid (CSF) or radiographic manifestations as revealed by neuraxis imaging. Potentially of use, though not commonly employed, today are use of biomarkers and protein profiling in the CSF. Symptomatic treatment is directed at pain including headache, nausea, and vomiting, whereas more specific LM-directed therapies include intra-CSF chemotherapy, systemic chemotherapy, and site-specific radiotherapy. A special emphasis in the review discusses novel agents including targeted therapies, that may be promising in the future management of LM. These new therapies include anti-epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors erlotinib and gefitinib in nonsmall cell lung cancer, anti-HER2 monoclonal antibody trastuzumab in breast cancer, anti-CTLA4 ipilimumab and anti-BRAF tyrosine kinase inhibitors such as vermurafenib in melanoma, and the antivascular endothelial growth factor monoclonal antibody bevacizumab are currently under investigation in patients with LM. Challenges of managing patients with LM are manifold and include determining the appropriate patients for treatment as well as the optimal route of administration of intra-CSF drug therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Self-citationResponse criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409 · cited 1×
“The one‐dimensional response evaluation criteria in solid tumors (RECIST) criteria are not appropriate for the evaluation of LM as the imaging features of LM (subarachnoid, ventricular or parenchymal enhancing nodules, focal or diffuse pial enhancement, ependymal, sulcal, folia or cranial nerve enhancements) in genera…”
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients
Bubendorf, L., Schöpfer, A., Wagner, U., Sauter, G., Moch, H., Willi, N., Gasser, T. C., & Mihatsch, M. J. (2000) · Human Pathology · doi:10.1053/hp.2000.6698 · Cited by 1,895 · cited 1×
“[119,166] Additionally, seeding of the leptomeninges via retrograde venous pathways along the valveless Batson’s venous plexus has been incriminated in pelvic cancers but this hypothesis remains speculative.[35,109]”
BackgroundBendell, J. C., Domchek, S. M., Burstein, H. J., Harris, L., Younger, J., Kuter, I., Bunnell, C., Rue, M., Gelman, R., & Winer, E. (2003) · Cancer · doi:10.1002/cncr.11436 · Cited by 1,320
Prognostic markers in triple‐negative breast cancer
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007) · Cancer · doi:10.1002/cncr.22381 · Cited by 1,283
Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
Wasserstrom, W. R., Glass, J. P., & Posner, J. B. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<759::aid-cncr2820490427>3.0.co;2-7 · Cited by 1,124
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Margolin, K., Ernstoff, M. S., Hamid, O., Lawrence, D., McDermott, D., Puzanov, I., Wolchok, J. D., Clark, J. I., Sznol, M., Logan, T. F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70090-6 · Cited by 1,091
Falchook, G. S., Long, G. V., Kurzrock, R., Kim, K. B., Arkenau, T. H., Brown, M. P., Hamid, O., Infante, J. R., Millward, M., Pavlick, A. C., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60398-5 · Cited by 943
Lin, N. U., Claus, E., Sohl, J., Razzak, A. R., Arnaout, A., & Winer, E. P. (2008) · Cancer · doi:10.1002/cncr.23930 · Cited by 727
Pegram, M., Hsu, S., Lewis, G., Pietras, R., Beryt, M., Sliwkowski, M., Coombs, D., Baly, D., Kabbinavar, F., & Slamon, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202526 · Cited by 692
Shapiro, W. R., Young, D. F., & Mehta, B. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507242930402 · Cited by 681
Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors
Sawaya, R., Hammoud, M., Schoppa, D., Hess, K. R., Wu, S. Z., Shi, W.-M., & WiIdrick, D. M. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00054 · Cited by 644
Infiltration of the Leptomeninges by Systemic Cancer: A Clinical and Pathologic Study
Olson, M. E., Chernik, N. L., & Posner, J. B. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320010002 · Cited by 584
Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529
Self-citationMalignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology
Glass, J. P., Melamed, M., Chernik, N. L., & Posner, J. B. (1979) · Neurology · doi:10.1212/wnl.29.10.1369 · Cited by 493
Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors
Ebersold, M. J. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00058 · Cited by 488
Aparicio, A., & Chamberlain, M. C. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0081-7 · Cited by 487
Self-citationThe central nervous system in childhood leukemia.II. Subacute leukoencephalopathy
Price, R. A., & Jamieson, P. A. (1975) · Cancer · doi:10.1002/1097-0142(197502)35:2<306::aid-cncr2820350203>3.0.co;2-j · Cited by 479
Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results
Glantz, M. J., Cole, B. F., Glantz, L. K., Cobb, J., Mills, P., Lekos, A., Walters, B. C., & Recht, L. D. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z · Cited by 456
Leptomeningeal metastases in the MRI era
Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a69 · Cited by 432
Stemmler, H.-J., Schmitt, M., Willems, A., Bernhard, H., Harbeck, N., & Heinemann, V. (2007) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000236313.50833.ee · Cited by 412
Glantz, M. J., LaFollette, S., Jaeckle, K. A., Shapiro, W., Swinnen, L., Rozental, J. R., Phuphanich, S., Rogers, L. R., Gutheil, J. C., Batchelor, T., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3110 · Cited by 402
Self-citationGrossman, S. A., Finkelstein, D. M., Ruckdeschel, J. C., Trump, D. L., Moynihan, T., & Ettinger, D. S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.561 · Cited by 364
Hitchins, R. N., Bell, D. R., Woods, R. L., & Levi, J. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1655 · Cited by 352
Grommes, C., Oxnard, G. R., Kris, M. G., Miller, V. A., Pao, W., Holodny, A. I., Clarke, J. L., & Lassman, A. B. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor121 · Cited by 349 · cited 2×
“[50] After reestablishment of CSF flow, the survival of patients with pretreatment CSF flow interruption is similar to patients without flow abnormalities.[39,42,50,111,122,190] Table 3: Symptoms and signs at LM diagnosis (adapted from Chamberlain 2009 and Groves 2008)”
BackgroundMethodIntrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
Blasberg, R. G., Patlak, C., & Fenstermacher, J. D. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30311-3 · Cited by 343
Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal Leukemia
Bleyer, W. A., Drake, J. C., & Chabner, B. A. (1973) · New England Journal of Medicine · doi:10.1056/nejm197310112891503 · Cited by 337
Glantz, M. J., Cole, B. F., Recht, L., Akerley, W., Mills, P., Saris, S., Hochberg, F., Calabresi, P., & Egorin, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1561 · Cited by 322
Kaplan, J. G., DeSouza, T. G., Farkash, A., Shafran, B., Pack, D., Rehman, F., Fuks, J., & Portenoy, R. (1990) · Journal of Neuro-Oncology · doi:10.1007/bf02341153 · Cited by 308
Pestalozzi, B. C., & Brignoli, S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2349 · Cited by 301
Boogerd, W., van den Bent, M. J., Koehler, P. J., Heimans, J. J., van der Sande, J. J., Aaronson, N. K., Hart, A. A. M., Benraadt, J., & Vecht, C. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.012 · Cited by 286
Morris, P. G., Reiner, A. S., Szenberg, O. R., Clarke, J. L., Panageas, K. S., Perez, H. R., Kris, M. G., Chan, T. A., DeAngelis, L. M., & Omuro, A. M. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182398e4f · Cited by 280
Gleissner, B., & Chamberlain, M. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70443-4 · Cited by 277
Self-citationChamberlain, M. C., Sandy, A. D., & Press, G. A. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.435 · Cited by 265
Self-citationJackman, D. M., Holmes, A. J., Lindeman, N., Wen, P. Y., Kesari, S., Borras, A. M., Bailey, C., de Jong, F., Jänne, P. A., & Johnson, B. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6126 · Cited by 260
Central Nervous System Cancers
Nabors, L. B., Ammirati, M., Bierman, P. J., Brem, H., Butowski, N., Chamberlain, M. C., DeAngelis, L. M., Fenstermaker, R. A., Friedman, A., Gilbert, M. R., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0132 · Cited by 247
Self-citationBevacizumab Safety in Patients with Central Nervous System Metastases
Besse, B., Lasserre, S. F., Compton, P., Huang, J., Augustus, S., & Rohr, U.-P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2439 · Cited by 241
The Role of Postoperative Radiotherapy after Resection of Single Brain Metastases
DeAngelis, L. M., Mandell, L. R., Thaler, H. T., Kimmel, D. W., Galicich, J. H., Fuks, Z., & Posner, J. B. (1989) · Neurosurgery · doi:10.1227/00006123-198906000-00002 · Cited by 230
Raizer, J. J., Hwu, W.-J., Panageas, K. S., Wilton, A., Baldwin, D. E., Bailey, E., von Althann, C., Lamb, L. A., Alvarado, G., Bilsky, M. H., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-058 · Cited by 230
Omuro, A. M. P., Kris, M. G., Miller, V. A., Franceschi, E., Shah, N., Milton, D. T., & Abrey, L. E. (2005) · Cancer · doi:10.1002/cncr.21033 · Cited by 228
Breast cancer subtypes and survival in patients with brain metastases
Nam, B.-H., Kim, S. Y., Han, H.-S., Kwon, Y., Lee, K. S., Kim, T. H., & Ro, J. (2008) · Breast Cancer Research · doi:10.1186/bcr1870 · Cited by 224
The role of postoperative radiotherapy after resection of single brain metastases
DeAngelis, L. M., Mandell, L. R., Thaler, H. T., Kimmel, D. W., Galicich, J. H., Fuks, Z., & Posner, J. B. (1989) · Neurosurgery · doi:10.1097/00006123-198906000-00002 · Cited by 217
Clarke, J. L., Pao, W., Wu, N., Miller, V. A., & Lassman, A. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0128-6 · Cited by 214 · cited 5×
“Whether erlotinib should be prescribed in LM at standard dose or high‐dose is not clear.[72,87] Some authors report the pharmacokinetic and therapeutic advantage of a high‐dose intermittent pulsatile schedule of EGFR inhibitor (1000‐1500 mg/week) in patients with LM.”
BackgroundInfluentialKesari, S., & Batchelor, T. T. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00032-4 · Cited by 211
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment
Boogerd, W. J., Hart, A. A. M., van der Sande, J. J., & Engelsman, E. (1991) · Cancer · doi:10.1002/1097-0142(19910315)67:6<1685::aid-cncr2820670635>3.0.co;2-m · Cited by 204
Leptomeningeal carcinomatosis: How does cancer reach the pia-arachnoid?
Kokkoris, C. P. (1983) · Cancer · doi:10.1002/1097-0142(19830101)51:1<154::aid-cncr2820510130>3.0.co;2-k · Cited by 201
Jabbour, E., O'Brien, S., Kantarjian, H., Garcia-Manero, G., Ferrajoli, A., Ravandi, F., Cabanillas, M., & Thomas, D. A. (2007) · Blood · doi:10.1182/blood-2006-08-043646 · Cited by 193
Chamberlain, M. C. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833de986 · Cited by 193
Self-citationGlantz, M., Hall, W. A., Cole, B. F., Chozick, B. S., Shannon, C., Wahlberg, L. U., Akerley, W., Marin, L., & Choy, H. (1995) · Cancer · Cited by 192
Altundag, K., Bondy, M. L., Mirza, N. Q., Kau, S., Broglio, K., Hortobagyi, G. N., & Rivera, E. (2007) · Cancer · doi:10.1002/cncr.23088 · Cited by 189
Survival of breast cancer patients with meningeal carcinomatosis
Gauthier, H., Guilhaume, M. N., Bidard, F. C., Pierga, J. Y., Girre, V., Cottu, P. H., Laurence, V., Livartowski, A., Mignot, L., & Diéras, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq232 · Cited by 187
Park, J. H., Kim, Y. J., Lee, J.-O., Lee, K.-W., Kim, J. H., Bang, S.-M., Chung, J.-H., Kim, J. S., & Lee, J. S. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.022 · Cited by 174
Leptomeningeal metastasis: survival and prognostic factors in 155 patients
Herrlinger, U., Förschler, H., Küker, W., Meyermann, R., Bamberg, M., Dichgans, J., & Weller, M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.008 · Cited by 173
Leptomeningeal metastases from solid malignancy: a review
Taillibert, S., Laigle-Donadey, F., Chodkiewicz, C., Sanson, M., Hoang-Xuan, K., & Delattre, J.-Y. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8101-x · Cited by 169
Self-citationCerebrospinal fluid flow abnormalities in patients with neoplastic meningitis
Grossman, S. A., Trump, D. L., Chen, D. C. P., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90404-1 · Cited by 161
Central Nervous System Cancers Clinical Practice Guidelines in Oncology
Brem, S. S., Bierman, P. J., Black, P. M., Blumenthal, D. T., Brem, H., Chamberlain, M. C., Chiocca, E. A., DeAngelis, L. M., Fenstermaker, R. A., Fine, H. A., et al. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0038 · Cited by 161
Self-citationKatayama, T., Shimizu, J., Suda, K., Onozato, R., Fukui, T., Ito, S., Hatooka, S., Sueda, T., Hida, T., Yatabe, Y., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181b62572 · Cited by 159
Rollins, N. K., Winick, N. J., Bash, R. O., & Booth, T. N. (2004) · PubMed Central · Cited by 158
Extended CSF cytarabine exposure following intrathecal administration of DTC 101.
Kim, S., Chatelut, É., Kim, J. C., Howell, S. B., Cates, C., Kormanik, P. A., & Chamberlain, M. C. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2186 · Cited by 157
Self-citationBokstein, F., Lossos, A., & Siegal, T. (1998) · PubMed · Cited by 153
MR imaging of leptomeningeal metastases: comparison of three sequences.
Singh, S. K., Leeds, N. E., & Ginsberg, L. E. (2002) · PubMed · Cited by 152
Prognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastases
Chamberlain, M. C., & Kormanik, P. A. (1996) · Neurology · doi:10.1212/wnl.46.6.1674 · Cited by 146
Self-citationWaki, F., Ando, M., Takashima, A., Yonemori, K., Nokihara, H., Miyake, M., Tateishi, U., Tsuta, K., Shimada, Y., Fujiwara, Y., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9758-3 · Cited by 145 · cited 2×
“…Grossman et al., 1993 Chamberlain 2002 Glantz et al., 1999 Kim et al., 2003 Herrlinger et al., 2004 Lassman et al.,[174] 2006 Groves et al., 2008 Waki et al., 2009 Clarke et al., 2010 Oeschle et al., 2010 Jimenez Mateos et al.,[153] 2011 Gani et al.,[106] 2012 Segura et al., 2012 90 patients…”
BackgroundMeningeal carcinomatosis in breast cancer: prognostic factors and outcome
de Azevedo, C. R. A. S., Cruz, M. R. S., Chinen, L. T. D., Peres, S. V., Peterlevitz, M. A., Pereira, A. E. D. A., Fanelli, M. F., & Gimenes, D. L. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0524-y · Cited by 145
Cytosine arabinoside cerebrospinal fluid kinetics
Zimm, S., Collins, J. M., Miser, J. S., Chatterji, D. C., & Poplack, D. G. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.120 · Cited by 142
Breast cancer leptomeningeal metastasis—the role of multimodality treatment
Rudnicka, H., Niwińska, A., & Murawska, M. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9340-4 · Cited by 141
Carcinoma Meningitis Secondary to Non–Small Cell Lung Cancer: Combined Modality Therapy
Chamberlain, M. C., & Kormanik, P. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.4.506 · Cited by 141
Self-citationGonzalez-Vitale, J. C., & Garcia‐Bunuel, R. (1976) · Cancer · Cited by 140
Siegal, T., Lossos, A., & Pfeffer, M. R. (1994) · Neurology · doi:10.1212/wnl.44.8.1463 · Cited by 138
Fizazi, K. S., Asselain, B. J. R., Vincent‐Salomon, A., Jouve, M., Dieras, V. C., Palangié, T., Beuzeboc, P., Dorval, T., & Pouillart, P. (1996) · Cancer · Cited by 136
Prognostic factors and outcomes in patients with leptomeningeal melanomatosis
Harstad, L., Hess, K. R., & Groves, M. D. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-062 · Cited by 136
Leptomeningeal metastases: A review of evaluation and treatment
Chamberlain, M. C. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005976926058 · Cited by 128
Self-citationRadioisotope CSF flow studies in leptomeningeal metastases
Chamberlain, M. C. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005982826121 · Cited by 128
Self-citationYi, H. G., Kim, H. J., Kim, Y. J., Han, S., Oh, D., Lee, S., Kim, D., Im, S., Kim, T., Kim, C. S., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.016 · Cited by 128
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Groves, M. D., Glantz, M., Chamberlain, M. C., Baumgartner, K., Conrad, C. A., Hsu, S. H., Wefel, J. S., Gilbert, M. R., Ictech, S. E., Hunter, K., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-059 · Cited by 128
Self-citationGefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation
Choong, N. W., Dietrich, S., Seiwert, T. Y., Tretiakova, M., Nallasura, V., Davies, G. C., Lipkowitz, S., Husain, A. N., Salgia, R., & Ma, P. C. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0400 · Cited by 126
Systemic high-dose intravenous methotrexate for central nervous system metastases
Lassman, A. B., Abrey, L. E., Shah, G. G., Panageas, K. S., Begemann, M., Malkin, M. G., & Raizer, J. J. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9044-6 · Cited by 124
Jaeckle, K. A., Phuphanich, S., van den Bent, M. J., Aiken, R. D., Batchelor, T. T., Campbell, T., Fulton, D. S., Gilbert, M. R., Heros, D. O., Rogers, L. R., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1574 · Cited by 121
Self-citationOechsle, K., Lange-Brock, V., Kruell, A., Bokemeyer, C., & de Wit, M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0831-x · Cited by 119
Mason, W. P., Yeh, S. D. J., & DeAngelis, L. M. (1998) · Neurology · doi:10.1212/wnl.50.2.438 · Cited by 115
Weber, J. S., Amin, A., Minor, D. R., Siegel, J., Berman, D., & O'Day, S. J. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e32834d3d88 · Cited by 114
Ahn, J. H., Lee, S. H., Kim, S., Joo, J., Yoo, H., Lee, S., Shin, S. H., & Gwak, H. (2012) · Journal of neurosurgery · doi:10.3171/2012.1.jns111560 · Cited by 113
Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases
Boyle, R., Thomas, M., & Adams, J. H. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.653.149 · Cited by 111
Glantz, M., Horn, A. V., Fisher, R., & Chamberlain, M. C. (2010) · Cancer · doi:10.1002/cncr.24921 · Cited by 110
Self-citationDetection of cancer cells in the cerebrospinal fluid: current methods and future directions
Weston, C. L., Glantz, M., & Connor, J. R. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-14 · Cited by 110
Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia
Johnson, V. G., Wrobel, C. J., Wilson, D., et al. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.70.2.0240 · Cited by 110
White, R. L., Schwartzentruber, D. J., Guleria, A. S., Macfarlane, M., White, D. E., Tucker, E. E., & Rosenberg, S. A. (1994) · Cancer · doi:10.1002/1097-0142(19941215)74:12<3135::aid-cncr2820741212>3.0.co;2-8 · Cited by 108
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
Braganca, K. C. D., Janjigian, Y. Y., Azzoli, C. G., Kris, M. G., Pietanza, M. C., Nolan, C. P., Omuro, A. M. P., Holodny, A. I., & Lassman, A. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0200-2 · Cited by 103
Chamberlain, M. C., & Kormanik, P. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005803918194 · Cited by 100
Self-citationGroves, M. D. (2010) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2010.08.006 · Cited by 100
Strazielle, N., Khuth, S. T., & Ghersi‐Egea, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.006 · Cited by 98
Masuda, T., Hattori, N., Hamada, A., Iwamoto, H., Ohshimo, S., Kanehara, M., Ishikawa, N., Fujitaka, K., Haruta, Y., Murai, H., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1555-6 · Cited by 98
Chamberlain, M. C., Khatibi, S., Kim, J. C., Howell, S. B., Chatelut, E., & Kim, S. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540030027009 · Cited by 96
Self-citationPatel, A. S., Allen, J. E., Dicker, D. T., Peters, K. L., Sheehan, J. M., Glantz, M., & El‐Deiry, W. S. (2011) · Oncotarget · doi:10.18632/oncotarget.336 · Cited by 96
Chamberlain, M. C. (2002) · Cancer · doi:10.1002/cncr.10547 · Cited by 93
Self-citationLeptomeningeal metastasis after surgical resection of brain metastases
van der Ree, T. C., Dippel, D. W. J., Avezaat, C. J. J., et al. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.225 · Cited by 89
Siegal, T. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005999228846 · Cited by 86
Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab
Platini, C., Long, J., & Walter, S. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70864-6 · Cited by 86
Lee, S. H., Ahn, H. K., Park, Y. H., Nam, D. H., Lee, J. I., Park, W., Choi, D. H., Huh, S. J., Park, K. T., Ahn, J. S., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1682-0 · Cited by 86
Intraventricular Immunotoxin Therapy for Leptomeningeal Neoplasia
Laske, D. W., Muraszko, K. M., Oldfield, E. H., DeVroom, H. L., Sung, C., Dedrick, R. L., Simon, T. R., Colandrea, J., Copeland, C., Katz, D., et al. (1997) · Neurosurgery · doi:10.1097/00006123-199711000-00005 · Cited by 86
New Strategies in the Management of Leptomeningeal Metastases
Groves, M. D. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.18 · Cited by 85
Topotecan Central Nervous System Penetration Is Altered by a Tyrosine Kinase Inhibitor
Zhuang, Y., Fraga, C. H., Hubbard, K. E., Hagedorn, N. L., Panetta, J. C., Waters, C. M., & Stewart, C. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0929 · Cited by 85
Dekker, L. J. M., Boogerd, W. J., Stockhammer, G., Dalebout, J. C., Siccama, I., Zheng, P., Bonfrèr, J. M. G., Verschuuren, J. J. G. M., Jenster, G. W., Verbeek, M. M., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500081-mcp200 · Cited by 84
Strong, J. M., Collins, J. M., McCully, C. L., & Poplack, D. G. (1986) · PubMed · Cited by 83
Kim, D.-Y. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg118 · Cited by 83
Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markers
Chamberlain, M. C. (1998) · Neurology · doi:10.1212/wnl.50.4.1173 · Cited by 83
Self-citationKim, H.-J., Im, S., Keam, B., Kim, Y.-J., Han, S., Kim, T. M., Oh, D., Kim, J. H., Lee, S., Chie, E. K., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0664-8 · Cited by 82
Neoplastic Meningitis From Systemic Malignancies: Diagnosis, Prognosis and Treatment
Jaeckle, K. A. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.016 · Cited by 81
Chamberlain, M. C. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0880-x · Cited by 80
Self-citationGroves, M. D., Hess, K. R., Puduvalli, V. K., Colman, H., Conrad, C. A., Gilbert, M. R., Weinberg, J. S., Cristofanilli, M., Yung, W. K. A., & Liu, T. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9819-2 · Cited by 80
Uhm, J. H. (2010) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(10)79301-7 · Cited by 78
Norris, L. K., Grossman, S. A., & Olivi, A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005723801479 · Cited by 77
Elliott, J. P., Keles, G. E., Waite, M. D., et al. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.5.0834 · Cited by 77
Gani, C., Müller, A., Eckert, F., Schroeder, C., Bender, B., Pantazis, G., BAMBERG, M., & Berger, B. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-0025-8 · Cited by 75
Frequency of unexplained meningeal enhancement in the brain after lumbar puncture.
Mittl, R. L., & Yousem, D. M. (1994) · PubMed · Cited by 75
A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid
Dux, R., Kindler‐Röhrborn, A., Annas, M., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90159-7 · Cited by 73
Cole, B. F., Glantz, M., Jaeckle, K. A., et al. (2003) · Cancer · doi:10.1002/cncr.11449 · Cited by 73
Bot, I., Blank, C. U., & Brandsma, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6488-4 · Cited by 72
Lin, N., Dunn, I. F., Glantz, M., Allison, D. L., Jensen, R. L., Johnson, M. D., Friedlander, R. M., & Kesari, S. (2011) · Journal of neurosurgery · doi:10.3171/2011.5.jns101768 · Cited by 70
Treatment Modalities for Leptomeningeal Metastases
Shapiro, W. R., Johanson, C. E., & Boogerd, W. J. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.05.006 · Cited by 66
Carcinomatous Meningitis in Non–Small-Cell Lung Cancer: Response to High-Dose Erlotinib
Dhruva, N., & Socinski, M. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0963 · Cited by 64
Witham, T. F., Fukui, M. B., MELTZER, C. C., Burns, R., Kondziolka, D. S., & Bozik, M. E. (1999) · Cancer · Cited by 63
Dummer, R., Rinderknecht, J. D., Goldinger, S. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.8548 · Cited by 62
Clatot, F., Philippin-Lauridant, G., Ouvrier, M.-J., Nakry, T., Laberge, S., Guillemet, C., Veyret, C., & Blot, E. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9940-2 · Cited by 61
Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.
Boogerd, W. J., Sande, J. J. V., & Moffie, D. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.10.1277 · Cited by 60
Fleischhack, G., Reif, S., Hasan, C., Jaehde, U., Hettmer, S., & Bode, U. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1841 · Cited by 59
Cerebrospinal Fluid in Diseases of the Nervous System, 2nd Ed.
Harik, S. I. (1994) · Neurology · doi:10.1212/wnl.44.8.1562 · Cited by 57
Burch, P. A., Grossman, S. A., & Reinhard, C. S. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.15.1211 · Cited by 54
Blaney, S. M., Poplack, D. G., Godwin, K. S., McCully, C. L., Murphy, R., & Balis, F. M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.177 · Cited by 53
List, J., Moser, R. P., Steuer, M. E., Loudon, W. G., Blacklock, J. B., & Grimm, E. A. (1992) · PubMed · Cited by 50
Shingyoji, M., Kageyama, H., Sakaida, T., Nakajima, T., Matsui, Y., Itakura, M., Iuchi, T., Yokoi, S., Kimura, H., & Iizasa, T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318219aaae · Cited by 49
Mego, M., Syčová-Milá, Z., Obertová, J., Rajec, J., Liskova, S., Palacka, P., Porsok, S., & Mardiak, J. (2011) · The Breast · doi:10.1016/j.breast.2011.05.007 · Cited by 49
Lamovec, J., & Zidar, A. (1991) · PubMed · Cited by 48
New aspects of immunotherapy of leptomeningeal metastasis
Herrlinger, U., Weller, M., & Schabet, M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005948722912 · Cited by 46
Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib
Sakai, M., Ishikawa, S., Ito, H., Ozawa, Y., Yamamoto, T., Onizuka, M., & Sakakibara, Y. (2006) · International Journal of Clinical Oncology · doi:10.1007/s10147-005-0558-x · Cited by 46
Özdoğan, M. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg046 · Cited by 45
Dicuonzo, F., Salvati, A., Palma, M., et al. (2009) · Journal of Child Neurology · doi:10.1177/0883073809332705 · Cited by 45
Les prises de contraste méningées normales et pathologiques en IRM
Dietemann, J., Bernardo, R. C., Bogorin, A., Eid, M. A., Koob, M., Nogueira, T., Vargas, M. I., Fakhoury, W., & Zollner, G. (2005) · Journal de Radiologie · doi:10.1016/s0221-0363(05)81507-0 · Cited by 45
Pérez‐Larraya, J. G., Palma, J., Carmona‐Iragui, M., Fernández‐Torrón, R., Irimia, P., Rodríguez‐Otero, P., Panizo, C., & Martínez‐Vila, E. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0428-x · Cited by 41
Esteva, F. J., Soh, L.-T., Holmes, F. A., Plunkett, W. K., Meyers, C. A., Forman, A. D., & Hortobágyi, G. N. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000173 · Cited by 41
Lb, M. (1977) · PubMed · Cited by 41
Novel approaches to treating leptomeningeal metastases
Grewal, J., Saria, M. G., & Kesari, S. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0686-2 · Cited by 39
Ostermann, K., Pels, H., Kowoll, A., Kuhnhenn, J., & Schlegel, U. S. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0435-y · Cited by 37
Gururangan, S., Petros, W. P., Poussaint, T. Y., Hancock, M. L., Phillips∥, P. C., Friedman, H. S., Bomgaars, L. R., Blaney, S. M., Kun, L. E., & Boyett, J. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2094 · Cited by 37
Leptomeningeal metastases in the MRI era
Chamberlain, M. C., Clarke, J. L., & DeAngelis, L. M. (2011) · Neurology · doi:10.1212/wnl.0b013e3181fac738 · Cited by 36
Self-citationTransverse myelopathy following intrathecal administration of chemotherapy.
Teh, H. S., Fadilah, S. A. W., & Leong, C. F. (2007) · PubMed · Cited by 35
Hashimoto, N., Imaizumi, K., Honda, T., Kawabe, T., Nagasaka, T., Shimokata, K., & Hasegawa, Y. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.016 · Cited by 35
Chamberlain, M. C., & Johnston, S. K. (2009) · Cancer · doi:10.1002/cncr.24210 · Cited by 35
Self-citationLeptomeningeal metastases: Reduction in regional cerebral blood flow and cognitive impairment
Siegal, T., Mildworf, B., Stein, D., & Melamed, E. (1985) · Annals of Neurology · doi:10.1002/ana.410170121 · Cited by 34
Renbarger, J. L., Aleksic, A., McGuffey, L., Dauser, R., Berg, S. L., & Blaney, S. M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0683-z · Cited by 34
A 4-Week Intrathecal Toxicity and Pharmacokinetic Study With Trastuzumab in Cynomolgus Monkeys
Braen, A. P. J. M., Perron, J., Tellier, P., Català, A., Kolaitis, G., & Geng, W. (2010) · International Journal of Toxicology · doi:10.1177/1091581810361527 · Cited by 31
Angiostatin prolongs the survival of mice with leptomeningeal metastases
Reijneveld, J. C., TAPHOORN, M. J. B., Kerckhaert, O. A. J., Drixler, T. A., Boogerd, W. J., & Voest, E. E. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01056.x · Cited by 27
Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum
Orphanos, G. S., & Ardavanis, A. S. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9298-z · Cited by 27
Hilgendorf, I., Wolff, D., Junghanß, C., Kahl, C., Leithaeuser, M., Steiner, B., Casper, J., & Freund, M. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0546-0 · Cited by 27
Methotrexate-induced posterior reversible encephalopathy syndrome
Aradillas, E., Arora, R., & Gasperino, J. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01207.x · Cited by 27
Park, I. H., Kwon, Y., Ro, J. Y., Lee, K. S., & Ro, J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0627-3 · Cited by 26
Simeone, E., Maio, E. D., Sandomenico, F., Fulciniti, F., Lastoria, S., Aprea, P., Staibano, S., Montesarchio, V., Palmieri, G., Mozzillo, N., et al. (2012) · Journal of Medical Case Reports · doi:10.1186/1752-1947-6-131 · Cited by 26
Intrathecal trastuzumab: dose matters
Höfer, S., Mengele, K., Stemmler, H., Schmitt, M., & Pestalozzi, B. C. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.673736 · Cited by 22
G�tling, E., Landis, T., & Kleihues, P. (1992) · Journal of Neurology · doi:10.1007/bf00833909 · Cited by 21
Benjamin, J. C., Moss, T. J. M., Mosely, R. P., et al. (1989) · Neurosurgery · doi:10.1227/00006123-198908000-00015 · Cited by 20
Tetsumoto, S., Osa, A., Kijima, T., Minami, T., Hirata, H., Takahashi, R., Kuhara, H., Nagatomo, I., Takeda, Y., Kida, H., et al. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0256-9 · Cited by 19
The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis
Brastianos, P. K., Brastianos, H. C., Hsu, W., Sciubba, D. M., Kosztowski, T. A., Tyler, B., Recinos, V. R., Burger, P. C., & Grossman, S. A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0655-9 · Cited by 18
Zaïri, F., Kotecki, N., Rodrigues, I., Baranzelli, M., Andre, C., Dubois, F., Devos, P., Faivre-Pierret, M., Assaker, R., Bonneterre, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.2070 · Cited by 12
Hata, A., Katakami, N., Kaji, R., Fujita, S., & Imai, Y. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824c96bc · Cited by 11
Normal and abnormal meningeal enhancement: MRI features
Bouraoui, I. H., Gamaoun, W., Mama, N., Moulahi, H., Daadoucha, A., Jemni, H., & Graiess, K. T. (2010) · Cited by 9
Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?
Lin, N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0720-7 · Cited by 7
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations
Li, Y.-S., Jiang, B.-Y., Yang, J.-J., Tu, H.-Y., Zhou, Q., Guo, W.-B., Yan, H.-H., & Wu, Y.-L. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.029 · Cited by 312
Kumthekar, P., Tang, S.-C., Brenner, A. J., Kesari, S., Piccioni, D. E., Anders, C., Carrillo, J., Chalasani, P., Kabos, P., Puhalla, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3258 · Cited by 250
Metadata
- Authors
- Chamberlain, M., Le Rhun, E., & Taillibert, S.
- Venue
- Surgical Neurology International
- Publisher
- Scientific Scholar
- Published
- 2013
- Volume
- 4
- Issue
- 5
- Pages
- 265
- ISSN
- 2152-7806 (ISSN-L)
- OpenAlex
- W81560840
- Cited by
- 338
- References
- 167
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.